target directory
oxi4503 combretastatin a1 diphosphate is a vascular targeted therapy that disrupts tumor vasculature clinical trial intelligence
Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.
Validated reports
0
Directory type
target
Association rule
normalized field
No validated trials yet
No public report currently matches this directory with a validated taxonomy rule.